Salmon Gal (6-Chloro-3-indoxyl-β-D-galactopyranoside)

<strong>Salmon Gal (6-Chloro-3-indoxyl-β-D-galactopyranoside)</strong>_x000D_ <strong>Catalog number:</strong> B2016186_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 329.73 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> 6-Chloro-3-indoxyl-β-D-galactopyranoside_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators; Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR, Turgeon AF, Escobedo J, Huang DT, Bradbury CA, Houston BL, Kornblith LZ, Kumar A, Kahn SR, Cushman M, McQuilten Z, Slutsky AS, Kim KS, Gordon AC, Kirwan BA, Brooks MM, Higgins AM, Lewis RJ, Lorenzi E, Berry SM, Berry LR, Aday AW, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Costantini TW, de Brouwer S, Derde LPG, Detry MA, Duggal A, Džavík V, Effron MB, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Galanaud JP, Galen BT, Gandotra S, García-Madrona S, Girard TD, Godoy LC, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Hamburg NM, Haniffa R, Hanna G, Hanna N, Hegde SM, Hendrickson CM, Hite RD, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Hudock K, Hunt BJ, Husain M, Hyzy RC, Iyer VN, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski AL, King AJ, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 N Engl J Med. 2021 Aug 26;385(9):790-802._x000D_ 2: REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators; Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ, Kahn SR, Marshall JC, Kim KS, Houston BL, Derde LPG, Cushman M, Tritschler T, Angus DC, Godoy LC, McQuilten Z, Kirwan BA, Farkouh ME, Brooks MM, Lewis RJ, Berry LR, Lorenzi E, Gordon AC, Ahuja T, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Contreras A, Costantini TW, de Brouwer S, Detry MA, Duggal A, Džavík V, Effron MB, Eng HF, Escobedo J, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Froess JD, Fu Z, Galanaud JP, Galen BT, Gandotra S, Girard TD, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Haniffa R, Hegde SM, Hendrickson CM, Higgins AM, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Huang DT, Hudock K, Hunt BJ, Husain M, Hyzy RC, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski A, King AJ, Knudson MM, Kornblith AE, Kutcher ME, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 N Engl J Med. 2021 Aug 26;385(9):777-789._x000D_ 3: Merkwitz C, Blaschuk O, Winkler J, Schulz A, Prömel S, Ricken AM. Advantages and Limitations of Salmon-Gal/Tetrazolium Salt Histochemistry for the Detection of LacZ Reporter Gene Activity in Murine Epithelial Tissue J Histochem Cytochem. 2017 Apr;65(4):197-206._x000D_ 4: Trifonov S, Yamashita Y, Kase M, Maruyama M, Sugimoto T. Overview and assessment of the histochemical methods and reagents for the detection of β-galactosidase activity in transgenic animals Anat Sci Int. 2016 Jan;91(1):56-67._x000D_ 5: Holmqvist BI, Carlberg M. Galanin receptors in the brain of a teleost: autoradiographic distribution of binding sites in the Atlantic salmon J Comp Neurol. 1992 Dec 1;326(1):44-60._x000D_ 6: Amoroso G, Ventura T, Cobcroft JM, Adams MB, Elizur A, Carter CG. Multigenic Delineation of Lower Jaw Deformity in Triploid Atlantic Salmon (Salmo salar L.) PLoS One. 2016 Dec 15;11(12):e0168454._x000D_ 7: Benktander J, Padra JT, Maynard B, Birchenough G, Botwright NA, McCulloch R, Wynne JW, Sharba S, Sundell K, Sundh H, Lindén SK. Gill Mucus and Gill Mucin O-glycosylation in Healthy and Amebic Gill Disease-Affected Atlantic Salmon Microorganisms. 2020 Nov 26;8(12):1871._x000D_ 8: Johansen A, Collet B, Sandaker E, Secombes CJ, Jørgensen JB. Quantification of Atlantic salmon type-I interferon using an Mx1 promoter reporter gene assay Fish Shellfish Immunol. 2004 Feb;16(2):173-84._x000D_ 9: Amano M, Amiya N, Hiramatsu M, Tomioka T, Oka Y. Interaction between neuropeptide Y immunoreactive neurons and galanin immunoreactive neurons in the brain of the masu salmon, Oncorhynchus masou Neurosci Lett. 2009 Oct 2;462(1):33-8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/25898318">10: Steichen AL, Simonson TJ, Salmon SL, Metzger DW, Mishra BB, Sharma J. Alarmin function of galectin-9 in murine respiratory tularemia PLoS One. 2015 Apr 21;10(4):e0123573. </a>_x000D_ _x000D_ <strong>Products Related to Salmon Gal (6-Chloro-3-indoxyl-β-D-galactopyranoside) can be found at</strong> <a href="https://moleculardepot.com/product-category/Substrates/"> Substrates</a>